ArticleBreast cancer research and treatment2024

Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer.

M Gaudio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.